Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

What doctors should know about ADHD in adults

A summary of earlier studies · The New England journal of medicine · Oct 14, 2026

What this means

This review describes ADHD in adults, including other conditions that often happen with it. It explains how doctors check for ADHD and how it is often treated.

Plain-English summary written by an AI model from the abstract. The original is below.

Tested inSummary of earlier studies
Who it was tested in
A review of earlier studies and clinical knowledge; no number of people given
Kind of research
A summary of earlier studies

The science

Original title
Adult Attention Deficit-Hyperactivity Disorder.
Authors
Buitelaar JK, Newcorn JH
Journal
The New England journal of medicine
Published
Oct 14, 2026
Study type
Review · in humans

Abstract

Attention deficit-hyperactivity disorder (ADHD) is a medical condition that is present in approximately 2.5% of adults worldwide and manifests in a variety of different ways across the lifespan. Adults with ADHD often have coexisting psychiatric disorders such as anxiety, mood, sleep, substance use, and personality disorders and are at increased risk for coexisting somatic conditions such as obesity, cardiovascular and cerebrovascular disease, type 1 and type 2 diabetes, and immune and inflammatory conditions. Hence, such adults may be seen by clinicians providing care for a wide range of psychiatric and somatic conditions. Nevertheless, ADHD remains unrecognized and undiagnosed in many persons. Assessment requires interviewing of the patient for core ADHD symptoms, coexisting conditions, and their functional effects, which can be facilitated by using standardized rating scales. Key components of treatment are psychoeducation and psychostimulant or nonstimulant medication, mostly in combination with psychosocial interventions and lifestyle guidance.

Read it on PubMed ↗

Buitelaar JK, Newcorn JH Adult Attention Deficit-Hyperactivity Disorder. The New England journal of medicine. 2026. doi:10.1056/NEJMcp2516040. PMID: 42874105. https://pubmed.ncbi.nlm.nih.gov/42874105/

Report a problem